Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
900
NCT01897896
Alternatives for Reducing Chorea in Huntington Disease
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 12, 2013
Completion: Aug 21, 2017
NCT02195700
Aim to Reduce Movements in Tardive Dyskinesia
Phase: Phase 2/3
Start: Jun 30, 2014
Completion: May 31, 2015
NCT02674321
A Pilot Study Of SD-809 (Deutetrabenazine) In Moderate To Severe Tourette Syndrome (TS)
Phase: Phase 1
Start: Jul 31, 2014
Completion: Jun 30, 2015
NCT02198794
Reducing Involuntary Movements in Participants With Tardive Dyskinesia
Start: Oct 20, 2014
Completion: Dec 14, 2020
NCT02291861
Addressing Involuntary Movements in Tardive Dyskinesia
Start: Oct 31, 2014
Completion: Aug 19, 2016